What Frensenius Vascular Care does

Fresenius Vascular Care, operating commercially as Azura Vascular Care, is a US-based specialty outpatient healthcare services company and a subsidiary of Fresenius Medical Care. Founded in 2005 and headquartered in Berwyn, Pennsylvania, the company develops and manages a network of 70+ outpatient vascular care centers across the United States staffed by 300+ interventional radiologists, interventional nephrologists, and vascular surgeons, supported by ACLS-certified nursing staff. The company employs 501-1,000 people and delivers a 4.8 patient satisfaction score across more than 7,500 ratings. The legal operating entity, Fresenius Vascular Care Long Beach MSO, LLC, is a California-based Management Services Organization, reflecting the multi-site physician practice structure typical of large ambulatory care operators.

The company's core product is a portfolio of nine minimally invasive, image-guided vascular procedures performed in outpatient settings: dialysis access management, uterine fibroid embolization, hemorrhoid artery embolization, peripheral artery disease procedures, ovarian vein embolization, varicose vein treatment, prostate artery embolization, kyphoplasty, and varicocele embolization. Procedures are delivered as same-day interventions designed to reduce recovery time relative to open surgical alternatives. Underlying technology centers on advanced interventional radiology imaging and minimally invasive catheter-based techniques rather than software platforms. The Fresenius Medical Care parent relationship provides brand credibility, operational infrastructure, and clinical expertise, particularly in the dialysis access management segment where parent-side patient flow is a structural advantage.

The business model is professional services revenue generated from procedure delivery, with pricing varying by procedure, insurance coverage, and patient circumstances; no public pricing exists. The go-to-market motion is sales-led and dual-channel: (1) physician referral networks, anchored by a refer-a-patient system that funnels patients from primary care, nephrology, and surgical practices into Azura centers; and (2) direct patient acquisition via a website, find-a-center locator, and organic social channels (Facebook, LinkedIn). The company additionally pursues growth through physician partnership pathways, including practice-joining and joint-venture structures with interventional specialists. Capital is raised through exempt securities offerings (Reg D filings) at the MSO entity level, with cumulative disclosed raises of approximately $23.9M across 2012-2023.

Name

Frensenius Vascular Care

Legal name

Fresenius Vascular Care Long Beach MSO, LLC

Website

https://freseniusvascularcare.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Fresenius Vascular Care (dba Azura Vascular Care), a subsidiary of Fresenius Medical Care, operates 70+ US outpatient vascular care centers delivering minimally invasive procedures including dialysis access management, uterine fibroid embolization, and peripheral artery disease treatment through 300+ specialized interventional physicians.

Ownership category

akta.pro rank

Product category

Outpatient Vascular Care Services

NAICS

Ambulatory Health Care Services (621), Offices of Physicians (62111), Offices of Physicians (6211)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Vascular Medicine (Peripheral Arterial/Venous Disease) (HLAKABAG)

akta.pro secondary industries

Interventional Nephrology (Dialysis Access Procedures) (HLAKAHAE), Pain Management & Interventional Procedure Centers (HLAFAIAH)

Keywords

• Outpatient vascular care
• Minimally invasive procedures
• Dialysis access management
• Interventional radiology
• Vascular surgery centers

Headquarters

HQ city

Berwyn

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Services Delivery: Revenue generated from providing outpatient vascular care procedures including dialysis access management, peripheral artery disease treatments, uterine fibroid embolization, and other minimally invasive vascular procedures at their network of 70+ centers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Fresenius Vascular Care, operating as Azura Vascular Care, develops and manages a network of 70+ specialty outpatient vascular centers across the United States that deliver minimally invasive, nonsurgical vascular procedures. Services include dialysis access management, uterine fibroid embolization, hemorrhoid artery embolization, peripheral artery disease treatments, ovarian vein embolization, varicose vein procedures, prostate artery embolization, kyphoplasty, and varicocele embolization, delivered by 300+ interventional radiologists, interventional nephrologists, and vascular surgeons.

Product overview

Azura Vascular Care, a Fresenius Medical Care company, operates as a network of 70+ outpatient vascular care centers delivering a comprehensive suite of minimally invasive vascular procedures. The company offers advanced, nonsurgical treatments across multiple service areas including dialysis access management, uterine fibroid embolization, hemorrhoid artery embolization, peripheral artery disease procedures, ovarian vein embolization, varicose veins procedures, prostate artery embolization, kyphoplasty, and varicocele embolization. These services are delivered by teams of interventional radiologists, interventional nephrologists, and vascular surgeons using state-of-the-art technology and the latest minimally invasive techniques. The network's 300+ specialists provide patient-first care with same-day procedures designed for minimal recovery time, supported by research-backed evidence-based practices.

Differentiator

Problem solved

Functional benefit

Products and services

• Dialysis Access Management Specialized vascular care service for managing dialysis access, ensuring proper function of hemodialysis access points for patients with kidney failure.
• Uterine Fibroid Embolization Minimally invasive procedure that blocks blood flow to uterine fibroids, causing them to shrink and relieving associated symptoms.
• Hemorrhoid Artery Embolization Minimally invasive procedure using image-guided techniques to reduce blood flow to hemorrhoids, providing relief without surgery.
• Peripheral Artery Disease Procedures Minimally invasive treatments for peripheral artery disease that restore blood flow to narrowed arteries in the limbs using advanced techniques.
• Ovarian Vein Embolization Minimally invasive procedure to treat ovarian vein reflux by blocking the affected vein, relieving associated pelvic pain.
• Varicose Veins Procedures Range of minimally invasive treatments for varicose veins using cutting-edge technology and latest techniques for effective vein treatment.
• Prostate Artery Embolization (PAE) Minimally invasive procedure that reduces blood flow to the prostate gland to treat benign prostatic hyperplasia (BPH) symptoms.
• Kyphoplasty Minimally invasive procedure to treat vertebral compression fractures by inserting a balloon to create space and then filling it with bone cement.
• Varicocele Embolization Minimally invasive procedure using image guidance to block enlarged veins in the scrotum, treating varicoceles without surgery.
• Other Medical Services Additional vascular and minimally invasive procedures available at Azura Vascular Care centers beyond the named core offerings.

Quantifiable outcome

• 4.8 patient satisfaction rating from over 7,500 ratings

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Fresenius Medical CarecoreStrategic or Co-development PartnerAzura Vascular Care is a subsidiary of Fresenius Medical Care, one of the largest healthcare companies focused on kidney disease treatment. This parent company relationship provides Azura with significant resources, brand recognition, and operational infrastructure across their network of vascular care centers.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• USA Vein Clinics: Operates a national network of outpatient clinics focused on minimally invasive varicose vein and vascular procedures. Directly comparable outpatient vascular care delivery model targeting similar patient conditions and using similar office-based interventional techniques.
• Center for Vein Restoration: Largest physician-led vein care practice in the US, providing outpatient treatment for varicose veins, spider veins, and related vascular conditions. Closely comparable specialty outpatient vascular model with similar service mix and patient demographic.
• Vein Clinics of America: Outpatient clinic network offering minimally invasive vein treatments and vascular care. Direct competitor in office-based vascular procedures with overlapping service lines such as varicose vein ablation and sclerotherapy.
• National Cardiovascular Partners: Operates outpatient cardiac and vascular catheterization labs and ambulatory surgery centers across the US. Comparable outpatient-focused specialty procedural platform serving referring physicians and patients in cardiovascular and vascular care.

Broad incumbents

• Surgery Partners: Large publicly traded operator of ambulatory surgery centers (ASCs) and surgical hospitals. Comparable as an outpatient specialty care platform with multiple service lines, though broader in scope than vascular-specific care.
• United Surgical Partners International (USPI): Major ASC operator owned by Tenet Healthcare, running hundreds of short-stay surgical facilities including vascular and interventional procedures. Comparable as a large-scale outpatient procedural platform with overlapping vascular service lines.
• HCA Healthcare: Largest US for-profit hospital operator with extensive vascular surgery, interventional radiology, and outpatient service lines. Represents the incumbent integrated delivery network that competes for vascular patient volumes and physician alignment.

Regional players

• US Renal Care: Large US dialysis provider with a patient population directly overlapping Azura's dialysis access management service line. Comparable as a Fresenius competitor in the renal ecosystem and a structural source of both referral opportunity and competitive pressure.

Emerging players

• Inari Medical: Medical device company developing catheter-based technologies for venous thromboembolism and peripheral vascular interventions. Adjacent emerging player whose devices are increasingly used by Azura-affiliated interventionalists, signaling technology direction in the field.
• Penumbra: Medical device company focused on vascular thrombectomy and embolization technologies used in interventional radiology and vascular procedures. Comparable as an enabling technology provider whose products are used in the same minimally invasive vascular procedures Azura performs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks3 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/AzuraVascularCare
• LinkedInlinkedin.com/company/fresenius-vascular-care
• Xx.com/FreseniusVC

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds7 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Frensenius Vascular Care